Frontier Biotechnologies Inc. (SHA:688221)

Frontier Biotechnologies Revenue

Frontier Biotechnologies had revenue of 44.73M CNY in the quarter ending September 30, 2025, with 10.22% growth. This brings the company's revenue in the last twelve months to 141.20M, up 5.63% year-over-year. In the year 2024, Frontier Biotechnologies had annual revenue of 129.47M with 13.32% growth.

• Revenue (ttm): 141.20M
• Revenue Growth: +5.63%
• P/S Ratio: 57.06
• Revenue / Employee: 467.56K
• Employees: 524
• Market Cap: 8.06B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	129.47M	15.22M	13.32%
Dec 31, 2023	114.25M	29.51M	34.82%
Dec 31, 2022	84.74M	44.24M	109.22%
Dec 31, 2021	40.50M	-6.12M	-13.13%
Dec 31, 2020	46.62M	25.76M	123.50%